Dechra Pharmaceuticals PLC — Major Shareholding Notification 2013

Sep 16, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1224O

Dechra Pharmaceuticals PLC

16 September 2013

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached: ii

Dechra Pharmaceuticals Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

In specie transfer out	ü

ü

3. Full name of person(s) subject to the

notification obligation: iii

Schroders plc

4. Full name of shareholder(s) (if different from 3.):iv

5. Date of the transaction and date on

which the threshold is crossed or

reached: v

13.09.13

6. Date on which issuer notified:

16.09.13

7. Threshold(s) that is/are crossed or

reached: vi, vii

Below 10%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights			% of  voting rights x
Direct		Direct xi		Indirect xii	Direct			Indirect
Ordinary GB0009633180	13,534,221			9,458,238			9,329,564		N/A		7,967,064	N/A			9.141%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii		Exercise/ Conversion Period xiv					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date xvii		Exercise/ Conversion period xviii			Number of voting rights instrument refers to				% of voting rights xix, xx
													Nominal			Delta
Total (A+B+C)
Number of voting rights								Percentage of voting rights
7,967,064								9.141%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Cazenove Capital Management Ltd                                               9,400              0.011% Schroder Investment Management Ltd                               7,312,116      8.390% Schroder Investment Management North America Limited         645,548          0.740%
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements.
14. Contact name:	Laura Whelan
15. Contact telephone number:	020 7658 6000

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLFMGMLKVZGFZM